Skip to main content
. 2022 Jan 22;14(2):262. doi: 10.3390/pharmaceutics14020262

Table 4.

Molecular docking and molecular dynamics (MD) simulation results of Gla (LicA)–enhancers–skin systems.

χ (kcal/mol) Emix (kcal/mol) CED (kcal/mol)
LicA-CP 90-Skin 27.54 16.31 1.49 × 109
LicA-IPM-Skin 24.82 14.70 1.37 × 109
LicA-NMP-Skin 39.04 23.12 1.59 × 109
LicA-PG-Skin 48.50 28.72 1.62 × 109
LicA-POCC-Skin 17.13 10.14 1.41 × 109
LicA-SP-Skin 16.74 9.92 1.35 × 109
LicA-TP-Skin 42.52 25.18 1.49 × 109
Gla-CP 90-Skin 10.82 6.41 1.30 × 109
Gla-IPM-Skin 6.97 4.13 1.39 × 109
Gla-NMP-Skin 28.00 16.58 1.46 × 109
Gla-PG-Skin 31.06 18.40 1.54 × 109
Gla-POCC-Skin 14.07 8.33 1.45 × 109
Gla-SP-Skin 1.44 0.86 1.54 × 109
Gla-TP-Skin 21.41 12.68 1.47 × 109